Experience

• 

  Biogen Idec International, Zug, Switzerland

  • Sr. Associate I, Global Medical Affairs

    • Mar 2010 - Mar 2011

    Operational lead for TOP (Tysabri Observational Program), a large (up to 3500 patients) multicenter (400 sites), multinational (15 countries) Phase IV study in Relapsing-Remitting Multiple Sclerosis, in close collaboration with Contract Research Organizations, Global Clinical Operations and the affiliates.

• 

  F. HOFFMANN – LA ROCHE Ltd, Basel, Switzerland

  • Global Studies Operations Manager

    • Dec 2007 - Feb 2010

    * Responsible for all operational aspects of global clinical studies, from study start-up to study closure, in close collaboration with the affiliates and vendors.* Management of a large post-approval commitment study with 2800 patients suffering from chronic kidney disease, comprising more than 150 centers in 23 countries (including Asia-Pacific and Latin America).

• 

  Biogen Idec International, Zug, Switzerlanmd

  • Manager, Medical Affairs International

    • Jan 2005 - May 2007

    * Managed, coordinated and supervised large international phase IIIb and IV studies in Multiple Sclerosis, in close collaboration within Biogen Idec and with Contract Research Organizations and affiliates / distributors worldwide. * As project leader managed successfully the “global adherence project”, a retrospective observational study conducted in 22 countries. * Managed all departments’ contracting, budgeting and finance issues, and ensured adherence to budget targets and timely execution of all outstanding accounts in line with contractual obligations.

• 

  Faculty of Medicine, University of Zurich, Switzerland

  • Science Administrator “Cancer Research”

    • Jul 2001 - Dec 2004

    * Planned, coordinated und realised projects related to basic, translational and clinical oncology research at both Zurich’s universities. * Established an interdisciplinary “Cancer Network Zurich”, which ensured greater awareness level of Zurich’s oncology research to international community.

  • Managing Director of “Center of Medical Research”

    • Jul 2001 - Dec 2004

    * Organized "Day of Clinical Research” at the faculty of medicine, an important scientific exchange platform between the numerous research groups. * Established and maintained an adequate website, informing the target audience concisely about faculty’s scientific competencies.

• 

  THE STANDFORD RESEARCH INSTITUTE (SRI) CONSULTING, Zurich, Switzerland

  • Health Care Consultant

    • Jan 2001 - Jun 2001

    Analysed relevant information sources and generated market research reports on various drugs and their therapeutic areas.

• 

  The R.W.JOHNSON PHARMACEUTICAL RESEARCH INSTITUTE^, Bassersdorf, Switzerland

  • Clinical Trials Manager

    • Mar 1997 - Jun 2000

    * Planned, co-ordinated, managed and supervised multinational phase II and III clinical trials on safety and efficacy of Epoetin alfa in patients suffering from cancer or chronic renal failure.* Established extensive information channels and productive business relationships with different teams in Switzerland and the US, as well as with the international operating companies worldwide. Thereby ensured smooth study conduct and high data quality, in compliance with given time frames.

• 

  The R.W.JOHNSON PHARMACEUTICAL RESEARCH INSTITUTE , Basserdorf, Switzerland

  • Head of “Medical Information Management” Department

    • Feb 1990 - Feb 1997

    * Guided a team of 8 information specialists, supervised and optimised all team’s activities* Assessed the scientific information needs of the worldwide clientele and ensured successful business activities through delivery of high quality information services.* Provided competent and prompt support to internal departments as well as to international operating companies worldwide with broad range of information services on pharmaceutical and clinical research and development.

• 

  INSTITUTE OF CLINICAL PHARMACOLOGY (ICP), Regensdorf, Switzerland

  • Clinical Research Associate

    • Jan 1989 - Jan 1990

    Organized, coordinated and monitored phase II and III international clinical trials. Built up a mutual trust with the investigators and ensured timely delivery of high quality data.

• 

  RESEARCH AND CONSULTING COMPANY (RCC), Ittingen, Switzerland

  • Director of Department “Chronic Toxicity Studies”

    • Jul 1988 - Dec 1988

    Guided long-term animal studies on chronic toxicity of various agents, organised and generated relevant scientific reports. Delivered high quality work, in spite of very ambitious timelines and the large number of projects running in parallel.

• 

  INSTITUTE OF RADIOBIOLOGY OF THE ZURICH UNIVERSITY, Zurich, Switzerland

  • Researcher

    • Jul 1979 - Mar 1988

    Independently organised, conducted, analysed and reported pre-clinical studies dealing with combined effects of ionising radiation and various agents (cytostatic drugs, heavy metals) on the prenatal development in rodents. Successfully published the study results in form of sixteen articles and presentations at scientific symposia and congresses.

• 

  SOCIETY FOR RADIATION AND ENVIRONMENTAL RESEARCH, Munich, Germany

  • “Guest Researcher” at the Institute of Pathology

    • Apr 1987 - Sep 1987

    Investigated histochemical effects of low radiation doses on the prenatal central nervous system and published the results in an acknowledged scientific journal.